Risk of hypercalcemia in patients with very high serum 25‐OH vitamin D levels

Autor: Esra Cil Sen, Emre Sedar Saygili, Yuksel Altuntas, Adnan Batman, Feyza Yener Ozturk, Duygu Yildiz, Rumeysa Selvinaz Erol, Muhammed Masum Canat
Rok vydání: 2021
Předmět:
Zdroj: International Journal of Clinical Practice
ISSN: 1742-1241
1368-5031
DOI: 10.1111/ijcp.14181
Popis: Objective We aimed to evaluate the risk of hypercalcemia in patients with very high levels of 25‐hydroxy vitamin D (25(OH)D). Methods The distribution of patients who were screened for 25(OH)D in our hospital between January 2014 and December 2018 was evaluated and patients with serum concentrations of 25(OH)D >88 ng/mL were selected. Then, biochemical parameters of the cases with 25(OH)D >88 ng/mL were compared according to calcium status, vitamin D level (group 1, 88‐100 ng/mL; group 2, 100‐150 ng/mL, and group 3, >150 ng/mL), and gender. Results A total of 282 932 patients who underwent 25(OH)D tests in our hospital were evaluated. A total of 1311 (0.5%) patients had very high 25(OH)D levels (>88 ng/mL). Four hundred and ninety‐five patients who met our inclusion criteria and had complete data participated in the study. The median age was 58 years (interquartile range [IQR] = 41‐71 years) and the median level of 25(OH)D was 104.6 mg/mL (IQR = 94.9‐124.9 ng/mL). Most of the subjects (83.7%) with very high 25(OH)D levels were normocalcemic. A weak inverse correlation was observed between 25(OH)D level and intact parathyroid hormone (iPTH) level (r = −0.118, P = .01), but no correlation between 25(OH)D and calcium levels was observed. Alkaline phosphatase (ALP) levels were significantly higher in males (P = .032), and age and iPTH levels were higher in females (P
Databáze: OpenAIRE